Skip to main content

16.05.2024 | Review

Mental Health Care for Children with Heart Disease and Their Families: Practical Approaches and Considerations for the Pediatric and Pediatric Cardiology Clinician

verfasst von: Amanda D. McCormick, Kriti Puri, S. Yukiko Asaki, Shahnawaz Amdani, Devyani Chowdhury, Julie S. Glickstein, Seda Tierney, Patricia Ibeziako, Melissa K. Cousino, Christina Ronai

Erschienen in: Pediatric Cardiology

Einloggen, um Zugang zu erhalten

Abstract

Mental health conditions are a common comorbidity among children living with heart disease. Children with congenital heart disease are more likely to have a mental health condition than their unaffected peers or peers with other chronic illnesses, and mental health risk persists across their lifetime. While poorer mental health in adults with congenital heart disease is associated with worse overall health outcomes, the association between mental health and cardiac outcomes for children with heart disease remains unknown. Despite this, it is suspected that mental health conditions go undiagnosed in children with heart disease and that many affected children and adolescents do not receive optimal mental health care. In this article, we review mental health in congenital heart disease across the lifespan, across domains of care, and across diagnoses. Further directions to support mental health care for children and adolescents with heart disease include practical screening and access to timely referral and mental health resources.
Literatur
1.
54.
Zurück zum Zitat Russo AM et al (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 61:1318–1368. https://doi.org/10.1016/j.jacc.2012.12.017CrossRefPubMed Russo AM et al (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 61:1318–1368. https://​doi.​org/​10.​1016/​j.​jacc.​2012.​12.​017CrossRefPubMed
55.
Zurück zum Zitat Al-Khatib SM et al (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the american college of cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 72:1677–1749. https://doi.org/10.1016/j.jacc.2017.10.053CrossRefPubMed Al-Khatib SM et al (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the american college of cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 72:1677–1749. https://​doi.​org/​10.​1016/​j.​jacc.​2017.​10.​053CrossRefPubMed
57.
Zurück zum Zitat Francis J, Johnson B, Niehaus M (2006) Quality of life in patients with implantable cardioverter defibrillators. Indian Pacing Electrophysiol J 6:173–181PubMedPubMedCentral Francis J, Johnson B, Niehaus M (2006) Quality of life in patients with implantable cardioverter defibrillators. Indian Pacing Electrophysiol J 6:173–181PubMedPubMedCentral
70.
Zurück zum Zitat Ackerman MJ et al (2011) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13:1077–1109. https://doi.org/10.1093/europace/eur245CrossRefPubMed Ackerman MJ et al (2011) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13:1077–1109. https://​doi.​org/​10.​1093/​europace/​eur245CrossRefPubMed
84.
Zurück zum Zitat Szafran E et al (2017) Influence of ablation therapy on the quality of life in children with supraventricular tachycardia. Eur Rev Med Pharmacol Sci 21:2550–2559PubMed Szafran E et al (2017) Influence of ablation therapy on the quality of life in children with supraventricular tachycardia. Eur Rev Med Pharmacol Sci 21:2550–2559PubMed
Metadaten
Titel
Mental Health Care for Children with Heart Disease and Their Families: Practical Approaches and Considerations for the Pediatric and Pediatric Cardiology Clinician
verfasst von
Amanda D. McCormick
Kriti Puri
S. Yukiko Asaki
Shahnawaz Amdani
Devyani Chowdhury
Julie S. Glickstein
Seda Tierney
Patricia Ibeziako
Melissa K. Cousino
Christina Ronai
Publikationsdatum
16.05.2024
Verlag
Springer US
Erschienen in
Pediatric Cardiology
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-024-03518-5

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.